Skip to content

California · Nonprofit

JAY N SCHAPIRA MD MEDICAL RESEARCH FOUNDATION INC

JAY N SCHAPIRA MD MEDICAL RESEARCH FOUNDATION INC (California) receives grants from 6 organizations whose IRS filings report $51,000 to it, the largest being ROBERT GORE RIFKIND FOUNDATION ($15,000). 1 of them have funded it in more than one year.

Revenue FY2024
$377k
Funders on record
6
Grants received
$51k
Net assets
$272k
1/6 repeat funderspeak grant-dependency 14%
01What it does

What Jay N Schapira Md Medical Research Foundation Inc does

Mission

Research in cardiac disease in order to understand the cause and develop treatment strategies for patients with systemic lupis erythematosus to develop novel non-pharmacologic treatment approaches to relieve angina pectoris.research into coronary artery imaging in patients undergoing percutaneous coronary intervention (pci). Specifically evaluating the utility of oct (optional coherence tomography) to assist in optimizing the results of pci.

As stated on its FY2024 Form 990.

Program

  1. Phase I - investigating the cellular origin of resident cardiac stem cells (cardiospheres) and clinically isolating them and preparing to determine their biology so that they might be infused into heart attack victims.phase ii - investigating into the significance of circulating endothelial progenitor cells in patients undergoing primary coronary interventions with drug-eluting stents and collecting data on endothelial progenitor cells at the time of these procedures.phase iii - continuing the randomized evaluation of intracoronary transplantation of bone marrow stem cells in acute myocardial infarction characterized by st segment elevation and transmural infarcts. Investigation of microvascular ischemia in systemic lupus erythematosus and ascertain improved, accurate diagnostic procedures.treatment of coronary artery disease, especially revascularization of the left main coronary artery (percutaneous coronary intervention in unprotected left main disease).evaulation and treatment of chest pain caused by microvascular ischemia for patients with systemic lupus erythematosus and publish results.educational publication for multifacet treatment of atrial fibrillation by medication and…

    $458,079 spent$345,918 earned by the program
    100% of program spending

The program described on its FY2023 Form 990. Program spending in total: $458,079.

02The organization over time

The organization over time

Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended.

100 = 20172017 Revenue 100 ($91k) Expenses 100 ($409k) Net assets 100 ($1.4M)2018 Revenue 206 ($188k) Expenses 103 ($422k) Net assets 84 ($1.2M)2019 Revenue 126 ($115k) Expenses 101 ($414k) Net assets 63 ($914k)2020 Revenue 131 ($119k) Expenses 99 ($405k) Net assets 43 ($628k)2021 Revenue 427 ($389k) Expenses 106 ($435k) Net assets 40 ($583k)2022 Revenue 77 ($70k) Expenses 121 ($495k) Net assets 11 ($158k)2023 Revenue 353 ($322k) Expenses 126 ($514k) Net assets -2 ($-34363)2024 Revenue 414 ($377k) Expenses 127 ($518k) Net assets 19 ($272k)
'17'18'19'20'21'22'23'24
Revenue (414)Expenses (127)Net assets (19)

Balance sheet

Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2021 to 2022, from $1.1M to $654k (−41%).

$1.4M
$1.2M
$914k
$719k
$1.1M
$654k
$467k
$312k
'17'18'19'20'21'22'23'24
Total assetsTotal liabilities

How it's funded, over time

Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.

2017
2018
2019
2020
2021
2022
2023
2024
ContributionsProgram revenueInvestmentOther

Government-grant reliance: 2021 16% · 2022 58%. Grants only. Government contracts and fees sit inside program revenue.

Surplus & reserves

Operating surplus or deficit each year, and months of liquidity in hand. 8 of the last 8 reported years ran a deficit.

−$318k
’17
−$235k
’18
−$300k
’19
−$286k
’20
−$46k
’21
−$425k
’22
−$193k
’23
−$141k
’24
1.7
months of
reserve

Leadership and staff

The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.

'17'18'19'20'21'22'23'24
Listed76555555
Joined·+0+0+0+0+1+0+0
No longer listed·1100100
03Who funds it

Who funds it, year by year

2017 → 2022: the base held at 1 funder, grant income rose $5k → $10k.

2 of 6 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 39% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.

From the IRS filings of JAY N SCHAPIRA MD MEDICAL RESEARCH FOUNDATION INC’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

How concentrated its funding is

JAY N SCHAPIRA MD MEDICAL RESEARCH FOUNDATION INC has a broad base — no single funder exceeds 29% of grant income, and it takes 3 funders to reach half.

the vertical line marks half of all grant income — 3 funders to its left

39% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund JAY N SCHAPIRA MD MEDICAL RESEARCH FOUNDATION INC.

29%
largest funder
69%
top three
~5
effective funders

Largest funder’s share by year: 2017 100% · 2018 100% · 2019 83% · 2021 40% · 2022 100% — broadly stable.

“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

Where its funders are

100% of JAY N SCHAPIRA MD MEDICAL RESEARCH FOUNDATION INC's grant income comes from California funders.

CA

In-state vs out-of-state, by year

’17
’18
’19
’21
California out of state home

Funder states come from each funder’s own filing. $20k arriving through sponsors registered in 2 states is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

04Its place in the field

Organizations like JAY N SCHAPIRA MD MEDICAL RESEARCH FOUNDATION INC

Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.

In California

Nationally

05Profile & governance

Read directly from this organization’s own Form 990, as neutral context.

Where the money goes

89% of spending goes to programs.

Program 89%Management 11%Fundraising 0%

Governance

6
board members
50%
independent
✓Conflict-of-interest policy–Whistleblower policy–Document retention✓Board reviewed the 990–Audited financials

Footprint & structure

Files a return copy in 1 state

CA

Part of a family of 3 related entities

  • Jns Consultants Inc · corp_trust
  • Jay N Schapira Md Inc · corp_trust
  • Schapira Executive Medical Services Inc · corp_trust

Screen this organization

A dated, signed PDF of the compliance screen for JAY N SCHAPIRA MD MEDICAL RESEARCH FOUNDATION INC: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.

A paid feature, included from the $75 plan up. Sign in to download.

Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf

Questions and answers

Who funds JAY N SCHAPIRA MD MEDICAL RESEARCH FOUNDATION INC?
JAY N SCHAPIRA MD MEDICAL RESEARCH FOUNDATION INC (California) receives grants from 6 organizations whose IRS filings report $51,000 to it, the largest being ROBERT GORE RIFKIND FOUNDATION ($15,000). 1 of them have funded it in more than one year.
How many funders does JAY N SCHAPIRA MD MEDICAL RESEARCH FOUNDATION INC have?
IRS filings report 6 organizations giving $51,000 in grants to JAY N SCHAPIRA MD MEDICAL RESEARCH FOUNDATION INC, 1 of which have funded it in more than one year.
Who is the largest funder of JAY N SCHAPIRA MD MEDICAL RESEARCH FOUNDATION INC?
ROBERT GORE RIFKIND FOUNDATION is the largest funder on record, with $15,000 in grants. The full list of funders is on this page.
How can an organization like JAY N SCHAPIRA MD MEDICAL RESEARCH FOUNDATION INC find more funders?
Start with the funders already giving here, then look at the foundations that back similar organizations in California. The funding by cause and by state pages list the largest funders for a given area and how to approach them.

These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2024 (financials across 2017–2024), and the filings of 6 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing